| Dr Gregory Ronald Zielinski, | |
|
157 E Woodside Ave, Patchogue, NY 11772-1421 | |
| (631) 475-1900 | |
| (631) 475-1955 |
| Full Name | Dr Gregory Ronald Zielinski |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 157 E Woodside Ave, Patchogue, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235661133 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 315683 (New York) | Primary |
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20081202000185 |
News Archive
South Dakota State University researchers are using the tools of spatial analysis to explore nationwide data for insights on what influences obesity."We can identify and map some of these regions or 'hotspots' of high and low obesity," said associate professor Michael Wimberly of SDSU's Geographic Information Science Center of Excellence. "Ultimately what we want to do is explain what some of the drivers are."
CIGNA (NYSE:CI) today announced the initial results of its multi-year strategy that places an entirely new focus on improving customers' experience. The effort has led to an improvement in customer understanding of their benefits in excess of 100 percent, a 50 percent reduction in the number of printed materials customers receive, and the use of simpler language that doesn't rely on insurance jargon. It also led CIGNA to become the first in its industry to offer 24 hour-a-day, seven day-a-week customer service.
Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed three-dimensional structure of the drugs interacting with an essential enzyme in the TB germ, also reveal why some TB drugs are more potent than others and suggest how drug developers can make fluoroquinolones more efficacious against mutations that make the lung disease drug resistant.
In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States. Vanderbilt University Medical Center's James Crowe, M.D., Ann Scott Carell Professor and director of the Vanderbilt Vaccine Center, and his team are reporting the first large panel of antibody treatments against this disease in the current issue of Cell Host and Microbe.
Cempra Pharmaceuticals today announced abstracts to be presented on its fourth generation macrolide and novel fluoroketolide antibiotic, solithromycin (CEM-101), at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 17 to 20, 2011, in Chicago. The abstracts provide additional data that demonstrate the safety and routes of administration of CEM-101, a new generation macrolide.
› Verified 9 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
South Dakota State University researchers are using the tools of spatial analysis to explore nationwide data for insights on what influences obesity."We can identify and map some of these regions or 'hotspots' of high and low obesity," said associate professor Michael Wimberly of SDSU's Geographic Information Science Center of Excellence. "Ultimately what we want to do is explain what some of the drivers are."
CIGNA (NYSE:CI) today announced the initial results of its multi-year strategy that places an entirely new focus on improving customers' experience. The effort has led to an improvement in customer understanding of their benefits in excess of 100 percent, a 50 percent reduction in the number of printed materials customers receive, and the use of simpler language that doesn't rely on insurance jargon. It also led CIGNA to become the first in its industry to offer 24 hour-a-day, seven day-a-week customer service.
Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed three-dimensional structure of the drugs interacting with an essential enzyme in the TB germ, also reveal why some TB drugs are more potent than others and suggest how drug developers can make fluoroquinolones more efficacious against mutations that make the lung disease drug resistant.
In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States. Vanderbilt University Medical Center's James Crowe, M.D., Ann Scott Carell Professor and director of the Vanderbilt Vaccine Center, and his team are reporting the first large panel of antibody treatments against this disease in the current issue of Cell Host and Microbe.
Cempra Pharmaceuticals today announced abstracts to be presented on its fourth generation macrolide and novel fluoroketolide antibiotic, solithromycin (CEM-101), at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 17 to 20, 2011, in Chicago. The abstracts provide additional data that demonstrate the safety and routes of administration of CEM-101, a new generation macrolide.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Ronald Zielinski, 122 Harvard St, Williston Park, NY 11596-1318 Ph: (516) 353-0283 | Dr Gregory Ronald Zielinski, 157 E Woodside Ave, Patchogue, NY 11772-1421 Ph: (631) 475-1900 |
News Archive
South Dakota State University researchers are using the tools of spatial analysis to explore nationwide data for insights on what influences obesity."We can identify and map some of these regions or 'hotspots' of high and low obesity," said associate professor Michael Wimberly of SDSU's Geographic Information Science Center of Excellence. "Ultimately what we want to do is explain what some of the drivers are."
CIGNA (NYSE:CI) today announced the initial results of its multi-year strategy that places an entirely new focus on improving customers' experience. The effort has led to an improvement in customer understanding of their benefits in excess of 100 percent, a 50 percent reduction in the number of printed materials customers receive, and the use of simpler language that doesn't rely on insurance jargon. It also led CIGNA to become the first in its industry to offer 24 hour-a-day, seven day-a-week customer service.
Biophysicists have discovered why the bacteria that cause tuberculosis (TB) are naturally somewhat resistant to antibiotics known as fluoroquinolones. Their findings, based on mapping the detailed three-dimensional structure of the drugs interacting with an essential enzyme in the TB germ, also reveal why some TB drugs are more potent than others and suggest how drug developers can make fluoroquinolones more efficacious against mutations that make the lung disease drug resistant.
In late 2013 the Caribbean had its first case of the mosquito-borne chikungunya virus. Today there have been almost 1.2 million cases in 44 countries or territories, including 177 cases in 31 U.S. States. Vanderbilt University Medical Center's James Crowe, M.D., Ann Scott Carell Professor and director of the Vanderbilt Vaccine Center, and his team are reporting the first large panel of antibody treatments against this disease in the current issue of Cell Host and Microbe.
Cempra Pharmaceuticals today announced abstracts to be presented on its fourth generation macrolide and novel fluoroketolide antibiotic, solithromycin (CEM-101), at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 17 to 20, 2011, in Chicago. The abstracts provide additional data that demonstrate the safety and routes of administration of CEM-101, a new generation macrolide.
› Verified 9 days ago
Thomas F. Gerold, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4 Phyllis Dr Ste B, Patchogue, NY 11772 Phone: 631-289-4700 Fax: 631-289-4718 | |
Badri Nath, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4 Phyllis Drive, Patchogue, NY 11772 Phone: 631-289-4700 Fax: 631-289-4718 | |
Dr. Stephen H Green, MD Surgery Medicare: Medicare Enrolled Practice Location: 285 Sills Rd, Building 2 Suite A, Patchogue, NY 11772 Phone: 631-475-8846 Fax: 631-475-8860 | |
Trichy Arumugam, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4 Phyllis Dr, Suite B, Patchogue, NY 11772 Phone: 631-289-4700 | |
Ravi Chandra Pulipati, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 33 Medford Ave, Suite A, Patchogue, NY 11772 Phone: 631-569-5410 Fax: 631-569-5413 | |
Gloria Chu, Surgery Medicare: Accepting Medicare Assignments Practice Location: 157 E Woodside Ave, Patchogue, NY 11772 Phone: 631-475-1900 |